Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
balderton capital
europe
fundings & exits
mytomorrows
sofinnova partners
startups
tc
What
drugs
2
×
patients
treatments
2
×
trials
2
×
way
access
amid
analysed
approval
benefits
big
broken
clinical
debate
design
designed
development
disrupt
dlc
dutch
evil
exaggerate
favour
flawed
funding
hopelessly
isn't
lengthy
malpractice
manufacture
marketing
medical
medicine
million
mytomorrows
needs
new
numbers
people
pharma
Language
Current search:
trials
×
treatments
×
drugs
×
@eurogamer.net
7 years ago
Even with the Marketing and Malpractice DLC, Big Pharma just isn't evil enough
@techcrunch.com
9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs